|
- Discusses the use of nutraceuticals for medical conditions such as dyslipidemia, hypertension, insulin resistance, and heart failure
- Includes the best clinical evidence supporting the use of nutraceuticals in cardiology
- Examines cardiovascular disease epidemiology, risk factors, and the role of dietary patterns
- Provides an evidence-based approach for the clinical use of nutraceuticals in the prevention and management of cardiovascular disease
This book provides an evidence-based approach for the clinical use of nutraceuticals in the prevention and management of cardiovascular disease. It examines cardiovascular disease epidemiology, risk factors, and the role of dietary patterns. Clinical chapters discuss the use of nutraceuticals in the management of medical conditions such as dyslipidemia, hypertension, insulin resistance, and heart failure. Each chapter contains a short epidemiological background; a list of relevant active compounds and their efficacy, tolerability, and safety; and suggestions for prescribers. This book is a practical guide with the best clinical evidence supporting the use of nutraceuticals in cardiology. Nutraceuticals and Cardiovascular Disease: An Evidence-based Approach for Clinical Practice is an essential resource for physicians, residents, fellows, and medical students in cardiology, clinical nutrition, dietetics, and internal medicine. Table of Contents- 1. Introduction to Cardiovascular Disease Epidemiology and Risk Factors.-
- 2. Definition of Nutraceuticals (Both Scientific and Legal).-
- 3. Evidence-based Approach to Nutraceuticals in Cardiovascular Medicine.-
- 4. Dietary Patterns and Cardiovascular Disease Risk: From Epidemiology to Intervention.-
- 5. Single Dietary Components and Cardiovascular Disease Risk: From Epidemiology to Intervention.-
- 6. Nutraceuticals for Dyslipidemia Management.-
- 7. Nutraceuticals for Hypertension Management.-
- 8. Nutraceuticals for Management of Insulin Resistance.-
- 9. Nutraceuticals Supporting Body Weight Loss.-
- 10. Nutraceuticals for Non-alcoholic Fatty Liver Disease Management.-
- 11. Nutraceuticals for Homocysteine Reduction.-
- 12. Nutraceuticals Supporting Cognitive Function in Mild Cognitive Impairment.-
- 13. Nutraceuticals Supporting Heart Function in Heart Failure.-
- 14. Nutraceuticals with Potential Adverse Cardiovascular Events or Pharmacological Interaction with Cardiometabolic Drugs.
|
